A prospective, multicenter, clinical outcome study of the NANOS neck preserving stem in patients with degenerative hip joint disease.

Recruiting

• Conditions: osteoarthritis; reumatoid arthritis; 10023213; 10005944

• Registration Number: NL-OMON46912
• Lead Sponsor: Smith&Nephew, Inc

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

Patients with degenerative hip disease, age 18-60, requiring a primary neck preserving hip arthroplasty (page 6).

Exclusion Criteria

Previous failed endoprosthesis, active local or systemic infection, general health with ASA>2, pronounced femur neck angle of <125 or >145 degrees, insufficient bone stock (femur or acetabulum), proven osteoporosis, body mass index >30. (page 7).

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Survival rate at 10 years follow- up.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Clinical outcome: HHS, HOOS, UCLA and radiographic findings.</p><br>